Search Details

Word: fda (lookup in dictionary) (lookup stats)
Dates: during 2000-2009
Sort By: most recent first (reverse)


Usage:

Advances in molecular biology and genomic medicine are increasing the odds that compounds dreamed up by scientists make it from the lab to the pharmacy. Here are some of the latest candidates, either just approved by the Food and Drug Administration (FDA) or under review. ?DIABETES If you're a diabetic and the daily injections of insulin are torture, then get ready for some relief. Pfizer received FDA approval in January to market the first inhaled insulin, Exubera, which should become available around midyear. The powdered insulin, taken just before meals, is released into the mouth and lungs through...

Author: /time Magazine | Title: Medicine: The New Cancer Fighter (And Other Hot Drugs On The Way) | 3/14/2006 | See Source »

...endocannabinoid system, a network of cells in the brain, the liver and fat tissue that regulates hunger by linking appetite to the body's reward and satisfaction system. Rimonabant reduces food cravings by deactivating the cannabinoid receptors. The drug, to be marketed as Acomplia, is being reviewed by the FDA and will be targeted at those who not only carry excess weight but also harbor unhealthy signs of metabolic disorders such as diabetes and hypertension. In half a dozen clinical trials, the compound helped 6,000 patients lose up to 10% of their body weight over a year and maintain...

Author: /time Magazine | Title: Medicine: The New Cancer Fighter (And Other Hot Drugs On The Way) | 3/14/2006 | See Source »

...FDA has approved the first ever transdermal patch for the treatment of depression. Simply remove the backing and press the patch firmly over your mother's mouth." --TINA...

Author: /time Magazine | Title: Punchlines: Mar. 20, 2006 | 3/12/2006 | See Source »

...lower LDL because those appear to do double duty, pumping up HDL levels 10% to 15%. And if that isn't enough, they are eyeing the arrival of HDL-boosting pills: Pfizer's torcetrapib is currently in clinical trials in combination with a statin and could be ready for FDA review in a year or two. "It's a look into the future of heart care," says Dr. Roger Blumenthal, director of Johns Hopkins Hospital's preventive cardiology program, of the new focus...

Author: /time Magazine | Title: Medicine: New Ways To Think About Old Diseases | 3/12/2006 | See Source »

With the Food and Drug Administration (FDA) stalling on a decision to make Plan B available over the counter--as recommended by its scientists--abortion-rights groups have moved aggressively to expand access at the state level. Eight states allow specially trained pharmacists to dispense the drug without a prescription as long as they follow state guidelines, including informing patients of all contraindications for Plan B and supplying the drug only to those who need it immediately. Seven more states are considering similar legislation. Massachusetts and Illinois require pharmacies to carry Plan B, and Connecticut and New York are contemplating...

Author: /time Magazine | Title: A Big Win For Plan B | 3/5/2006 | See Source »

Previous | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | Next